Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
D000818:Animals; D001369:Axons / Q000187:drug effects*; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000166:cytology / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D002250:Carbon Radioisotopes; D002395:Catecholamines / Q000378:metabolism; D002552:Cerebral Ventricles; D003984:Dibenzazepines / Q000494:pharmacology; D006651:Histocytochemistry; D006892:Hydroxydopamines / Q000494:pharmacology; D007211:Indoles / Q000378:metabolism; D007267:Injections; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D009474:Neurons / Q000187:drug effects; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013696:Temperature; D013997:Time Factors; D014363:Tryptamines / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity
D001679:Biogenic Amines; D002250:Carbon Radioisotopes; D002395:Catecholamines; D003984:Dibenzazepines; D006892:Hydroxydopamines; D007211:Indoles; D014363:Tryptamines; D012701:Serotonin